{"title":"Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib","authors":"N. Fadi, Ghoche Ahmad Al, D. Saada, Maddah Janah, Mansour Layal, kassem Ali, Gheith Abd El Karim","doi":"10.23937/IJOR-2017/1710009","DOIUrl":null,"url":null,"abstract":"• Page 1 of 3 • Citation: Nasr F, Al Ghoche A, Diab S, Maddah J, Mansour L, et al. (2018) Pembrolizumab Monotherapy in Relapsed Hepatocellular Carcinoma Post Living Donor Liver Transplantation and Sorafenib. Int J Oncol Res 1:009. Accepted: November 10, 2018; Published: November 12, 2018 Copyright: © 2018 Nasr F, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.","PeriodicalId":93572,"journal":{"name":"International journal of oncology research","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"International journal of oncology research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.23937/IJOR-2017/1710009","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 7
派姆单抗单药治疗活体肝移植后复发肝细胞癌和索拉非尼
•第1页，共3页•引文：Nasr F、Al Ghoche A、Diab S、Maddah J、Mansour L等人（2018）Pembrolizumab单药治疗活体肝移植和索拉非尼后复发性肝癌。Int J Oncol Res 1:009。受理时间：2018年11月10日；发布时间：2018年11月12日版权所有：©2018 Nasr F等人。这是一篇根据知识共享署名许可证条款分发的开放获取文章，该许可证允许在任何媒体上不受限制地使用、分发和复制，前提是原作者和来源可信。
本文章由计算机程序翻译，如有差异，请以英文原文为准。
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
